Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study (Q45285131)
Jump to navigation
Jump to search
scientific article published in March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study |
scientific article published in March 2005 |
Statements
1 reference
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study (English)
1 reference
Sverre E Kjeldsen
1 reference
Richard B Devereux
1 reference
Kristian Wachtell
1 reference
Mika Lehto
1 reference
Eva Gerdts
1 reference
Michael H Olsen
1 reference
Björn Hornestam
1 reference
Hans Ibsen
1 reference
Stevo Julius
1 reference
Lars H Lindholm
1 reference
Markku S Nieminen
1 reference
1 March 2005
1 reference
1 reference